Central laboratory research results published in international high-level journals

Research results of "Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway" by Lin Zhengfang, Gong Guifang, Li Yinghua/Associate Researcher (corresponding author) and Zhu Bing (corresponding author) Published on September 26, 2018 in the International Journal of Nanomedicine 2018:13, 5787-5797 (A1 area impact factor 4.37). This paper introduces functionalized nano-selenium synergistic ribavirin to inhibit host cell apoptosis induced by H1N1 influenza virus by inhibiting caspase-3 activity-mediated signaling pathway, and provide ideas and references for the preparation of novel anti-influenza virus nanomedicines.
(College of Science, Education and Data Management)
For more information, please click on the link: https://www.dovepress.com/restriction-of-h1n1-influenza-virus-infection-by-selenium-nanoparticle-peer-reviewed-article-IJN

Previous article:

Next article: